Alanine aminotransferase to hemoglobin ratio is an indicator for disease progression for hepatocellular carcinoma patients receiving transcatheter arterial chemoembolization
Crossref DOI link: https://doi.org/10.1007/s13277-015-4082-y
Published Online: 2015-09-28
Published Print: 2016-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lin, Zhi-Huan
Li, Xing
Hong, Ying-Fen
Ma, Xiao-Kun
Wu, Dong-Hao
Huang, MingSheng
Chen, Zhan-Hong
Chen, Jie
Dong, Min
Wei, Li
Wang, Tian-Tian
Ruan, Dan-Yun
Lin, Ze-Xiao
Zhong, Xiang
Xing, Yan-Fang
Wen, Jing-Yun
Wu, Xiang-Yuan
Lin, Qu
Text and Data Mining valid from 2015-09-28